Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
Go back to Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program| (NASDAQ: ZNTL) | Delayed: 3.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.59 | 52 Week High | $ | |||
| Open | $3.59 | 52 Week Low | $ | |||
| Day High | $3.59 | P/E | N/A | |||
| Day Low | $3.59 | EPS | $ | |||
| Volume | 598 | |||||
